What is bad science, and why is there so much of it?Read More
David O’Reilly, director of scientific research at BAT, shares his views on the roles of science and nicotine in tobacco harm reduction.Read More
Politics and data in tobacco harm reductionRead More
Quitting vaping early but continuing to smoke was the most common pattern.Read More
More robust and diverse data will help researchers develop predictive risk factor tools.Read More
Policymakers should be wary about THP harm reduction claims, say researchers.Read More
A study sheds light on impact of reduced-nicotine mandates. Read More
Bacteroides xylanisolvens can reduce smoking-exacerbated NAFLD progression.Read More
The results are currently being analyzed and will be published by the end of the year.Read More
The firm will use the funds to develop a proof of concept and apply for FDA authorization.Read More
Recent Posts
- Juul in Talks With Tobacco Companies
- Taiwan Set to Ban Nicotine Vapes
- Reynolds to Appeal Menthol Refill Rejections
- In Memoriam: Kay O’Neill
- FDA Denies Marketing of Two Vuse Menthol Vapor Products
- 22nd Century Acquires RX Pharmatech
- Pyxus Makes Board Changes
- Pouch Trade Secrets Dispute Settled
- 22nd Century Submits CBD Drug Master File
- Trade Group: Germans Smoking Less
- Pyxus Appoints New Chief HR Officer
- Preliminary Approval for Juul Settlement
- Court to Rehear Triton’s MDO Appeal
- Advocates Clarify Science Controversies
- Japan Tobacco Urged to Divest Drug Unit